Bond Yields Crush Stocks
Rising Treasury yields and tighter financial conditions pressure valuation multiples across healthcare and defensive growth names.
Previous verdicts for ABT
- AI Search: Abbott Rallies on FDA Approval for CardioMEMS Upgrade — 2026-10-05
- ABT Earnings Call Dip — 2026-09-30
- ABT drifts lower quietly — 2026-09-24
- FDA news weighs on shares — 2026-09-10
- Defensive Rotation Out — 2026-08-27
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works